Akero Therapeutics Inc (AKRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 90,236 | 80,873 | 80,882 | 78,025 | 81,703 |
| Operating Income | -90,236 | -80,873 | -80,882 | -78,025 | -81,703 |
| Interest Expense | 1,092 | 1,172 | 1,154 | 1,200 | 1,246 |
| Other Income | 9,762 | 11,540 | 11,311 | 9,201 | 10,244 |
| Pre-tax Income | -81,566 | -70,505 | -70,725 | -70,024 | -72,705 |
| Net Income Continuous | -81,566 | -70,505 | -70,725 | -70,024 | -72,705 |
| Net Income | $-81,566 | $-70,505 | $-70,725 | $-70,024 | $-72,705 |
| EPS Basic Total Ops | -0.99 | -0.86 | -0.90 | -0.99 | -1.05 |
| EPS Basic Continuous Ops | -0.99 | -0.86 | -0.90 | -1.00 | -1.05 |
| EPS Diluted Total Ops | -0.99 | -0.86 | -0.90 | -0.99 | -1.05 |
| EPS Diluted Continuous Ops | -0.99 | -0.86 | -0.90 | -1.00 | -1.05 |
| EPS Diluted Before Non-Recurring Items | -0.99 | -0.86 | 0.90 | -0.99 | -1.05 |
| EBITDA(a) | $-92,486 | $-83,547 | $-83,167 | $-80,848 | $-85,275 |